A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy
University of Michigan Rogel Cancer Center
University of Michigan Rogel Cancer Center
Servier
Providence Health & Services
Tanta University
Genentech, Inc.
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
Pfizer
Brooklyn ImmunoTherapeutics, LLC
Jiangsu HengRui Medicine Co., Ltd.
Merck KGaA, Darmstadt, Germany
Ipsen
pharmaand GmbH
Jiangsu HengRui Medicine Co., Ltd.
AstraZeneca
Jiangsu HengRui Medicine Co., Ltd.
Indiana University
Novartis
Brooklyn ImmunoTherapeutics, LLC
Novartis
National Institutes of Health Clinical Center (CC)
Maria Sklodowska-Curie National Research Institute of Oncology
Aragon Institute of Health Sciences
Bayer
Menarini International Operations Luxembourg SA
AstraZeneca
Daiichi Sankyo
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Astellas Pharma Inc
Sanofi
National Health Research Institutes, Taiwan
Mayo Clinic
Case Comprehensive Cancer Center
Cancer Advances Inc.
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
Takeda
Millennium Pharmaceuticals, Inc.